236 Users Online
A Detailed Analysis of the Coronary Artery Bypass Graft Market Based on Is Experiencing Robust Growth Driven by Increasing Prevalence of Cardiovascular Diseases, Technological Advancements in Surgical Procedures, and Rising Demand for Minimally Invasive Interventions
The global Coronary Artery Bypass Graft market is forecast to expand at a CAGR of 2.3% and thereby increase from a value of US$17.61 Bn in 2023 to US$20.65 Bn by the end of 2030.
Coronary Artery Bypass Graft Market Size (2023E)
Projected Market Value (2030F)
Global Market Growth Rate (CAGR 2023 to 2030)
Historical Market Growth Rate (CAGR 2018 to 2022)
Revenue Share of Top Four Countries (2022E)
To treat coronary artery disease, a coronary artery bypass graft (CABG) is a medical procedure that involves constructing a diversion around constricted or obstructed coronary arteries. By grafting a blood vessel, frequently from the patient's limb or chest, this surgical procedure reroutes blood flow around the obstructed vessels. By restoring adequate blood supply to the heart muscle, CABG seeks to reduce the risk of heart attack, alleviate chest pain, and improve heart function. Performing this procedure is of the utmost importance for patients who have severe coronary artery disease, as it serves to improve their overall cardiac health and quality of life.
The global market for coronary artery bypass grafts is propelled by several significant factors. The increasing incidence of coronary artery disease and the aging of the population are substantial contributors to the rising demand for CABG procedures. Additionally, technological advances in surgical instruments and techniques are vital to market expansion. Furthermore, the expansion of the market is facilitated by the enhanced healthcare infrastructure in emerging nations and the increasing awareness of the advantages of CABG. Additionally, a surge in lifestyle-related risk factors and the adoption of minimally invasive techniques contribute to the sustained expansion of the global coronary artery bypass graft market.
Increasing Prevalence of Coronary Artery Disease
The increasing prevalence of coronary artery disease (CAD) on a global scale is a significant factor propelling the Coronary Artery Bypass Graft (CABG) market. CAD continues to be a prominent contributor to morbidity and mortality on a global scale, impacting millions of individuals. The rise in cases of CAD is predominantly ascribed to modifications in lifestyle, such as increased inactivity, unhealthful eating practices, and a rising prevalence of obesity. The aforementioned elements contributory to the development of atherosclerotic lesions in the coronary arteries, which obstruct the supply of blood to the myocardium. Consequently, individuals diagnosed with CAD frequently manifest symptoms including angina, which is characterized by chest discomfort, and face an increased susceptibility to critical medical incidents such as myocardial infarctions. The substantial increase in demand for coronary artery bypass graft procedures has propelled the growth of the global CABG market, owing to the increasing prevalence of CAD.
The escalating incidence of CAD is significantly influenced by the aging of the global population, which in turn increases the demand for CABG procedures. The likelihood of developing cardiovascular diseases, such as CAD, increases substantially with advancing age. Physiological changes associated with aging contribute to the advancement of atherosclerosis and other risk factors associated with the cardiovascular system. Furthermore, it is common for older individuals to exhibit comorbidities, which increase their vulnerability to cardiac complications. The increasing elderly demographic in numerous geographical areas has generated a significant cohort of patients in need of coronary revascularization procedures, such as CABG. The aforementioned demographic transition not only highlights the critical nature of CAD treatment but also the enduring expansion prospects of the worldwide CABG industry.
Increasing Prevalence of Alternative Treatment Modalities
One notable factor restraining the expansion of the global Coronary Artery Bypass Graft (CABG) industry is the increasing prevalence of alternative treatment modalities, specifically minimally invasive techniques and progress in interventional cardiology. Coronary artery bypass grafting (CABG) has been widely regarded as the benchmark technique for revascularizing coronaries. However, the growing inclination towards less invasive alternatives, including percutaneous coronary interventions (PCI) such as angioplasty and stent implantation, presents a formidable obstacle to the conventional CABG market. Several benefits are associated with minimally invasive procedures; these include reduced hospital stays, shorter recovery periods, and fewer complications; as a result, they are an appealing option for both patients and healthcare providers. Furthermore, continuous progress in interventional cardiology methods enhances the effectiveness and safety of non-surgical substitutes.
Escalating Financial Strain
An influential factor affecting the worldwide Coronary Artery Bypass Graft (CABG) market is the escalating financial strain linked to healthcare costs, specifically in nations classified as low and middle-income. Coronary artery bypass grafting (CABG) operations, despite their notable efficacy in the treatment of coronary artery disease, may entail substantial financial burdens due to expenses associated with surgical intervention, postoperative care, and rehabilitation. A substantial segment of the populace might have restricted access to CABG procedures due to economic restrictions in specific regions, thereby impeding market expansion. In addition to the direct costs of the procedure, the financial burden associated with CABG also includes indirect costs associated with hospitalization, recovery, and follow-up care. In contexts with limited resources, the allocation of adequate funds to cardiovascular interventions may present a challenge for healthcare systems, resulting in inequities in the availability of CABG services.
Progress Made in Robotic-Assisted Surgery Technology
The global Coronary Artery Bypass Graft (CABG) market is propelled by the progress made in robotic-assisted surgery technology, which presents an advantageous opportunity. Robotic-assisted coronary artery bypass grafting (CABG) signifies a bright prospect in the domain of cardiovascular surgery, presenting prospective advantages in terms of patient outcomes, enhanced precision, and dexterity. Technological advancements of this nature possess the potential to fundamentally transform conventional CABG procedures, appealing to surgeons and patients alike who are in search of novel and minimally invasive substitutes. By utilizing robotic systems, surgeons are empowered to execute meticulous and precise maneuvers, thereby facilitating the execution of more delicate and complex tasks during bypass grafting.
The implementation of robotic-assisted CABG is consistent with the overall healthcare paradigm shift toward the utilization of minimally invasive methods. Patients can experience shorter incisions, diminished trauma to adjacent tissues, and expedited recovery periods through the implementation of robotic systems. In addition, the possibility of reduced postoperative pain and abbreviated hospital stays enhances the desirability of robotic-assisted CABG. With the ongoing development and recognition of technology in the medical field, coronary artery bypass graft (CABG) procedures could potentially enroll a broader range of patients, including those who were previously hesitant or ineligible for conventional open-heart surgery. As a result, robotic-assisted coronary artery bypass grafting (CABG) gains greater recognition as a viable and desirable option for surgeons and patients desiring optimal outcomes, this phenomenon provides a distinctive opportunity for market expansion.
The expansion of the global Coronary Artery Bypass Graft (CABG) market is anticipated to be significantly influenced by a confluence of factors. The increasing prevalence of coronary artery disease (CAD) on a global scale, developments in surgical technologies, shifting demographics, and a greater emphasis on cardiovascular health are significant contributors to this expansion. An aging population, sedentary occupations, and poor dietary practices all contribute to the increasing prevalence of CAD, which is the primary driver of the CABG market. It is anticipated that the demand for efficacious treatment modalities, such as coronary artery bypass graft procedures, will increase in tandem with the global prevalence of CAD. The increase in demand is especially conspicuous in areas where cardiovascular diseases are prevalent, thereby bolstering the market's trajectory of expansion. Profound contributions to the evolution of the market are made by developments in surgical techniques, including minimally invasive methods and robotic-assisted surgery. In addition to improving the accuracy and effectiveness of CABG procedures, these developments are also attractive to patients and healthcare professionals who are in search of minimally invasive treatments. It is anticipated that the adoption of such cutting-edge technologies will stimulate market expansion by increasing the number of eligible patients and enhancing overall procedural outcomes. In the CABG market, the relationship between manufacturers and consumers is vital for sustainable growth. There is a growing trend among manufacturers to prioritize collaborative endeavors with healthcare professionals to enhance patient satisfaction, optimize procedural outcomes, and foster the development of novel solutions. Ongoing efforts in research and development to improve surgical methodologies and create novel products have a significant impact on market dynamics. The reciprocal relationship between healthcare providers and manufacturers has a significant impact on the development of CABG procedures.
The global market for coronary artery bypass grafts (CABGs) is dominated by Medtronic plc, Abbott Laboratories, Terumo Corporation, and other major participants. The United States, Germany, and Japan are among the leading nations in which CABG procedures are being implemented, and these sector frontrunners have a significant international presence. For example, the extensive implementation of CABG procedures in the United States can be attributed to the innovative cardiovascular solutions developed by Abbott Laboratories and the advanced surgical technologies of Medtronic. Germany, renowned for its sophisticated healthcare infrastructure, makes extensive use of CABG, where Terumo Corporation serves as a key provider of state-of-the-art cardiovascular products. These market leaders are significant contributors to the expansion of the industry and exert considerable influence over its dynamics in critical healthcare centers across the globe.
The market leaders in CABG exert significant influence over its structure using ongoing innovation, strategic partnerships, and a determination to penetrate new markets. With its extensive range of medical technologies, Medtronic is spearheading progress in robotic-assisted coronary artery bypass graft procedures, thereby augmenting accuracy and improving patient results. Abbott Laboratories plays a significant role in the market by introducing innovative devices and diagnostic instruments for comprehensive cardiac care, as a result of its dedication to research and development. Access to CABG procedures in emerging markets is expanding as a result of Terumo Corporation's global partnerships and emphasis on technological integration. In general, these market leaders are not only improving the effectiveness of coronary artery bypass graft (CABG) procedures but also nurturing an environment that encourages innovation in cardiovascular healthcare and addressing emerging challenges.
What Technology Will Be Targeted the Most for Installations?
On-Pump CABG Segment to be Dominant owing to the Technique’s Well Established Presence
It is anticipated that the on-pump CABG segment will maintain its dominant market position for the foreseeable future. During on-pump coronary artery bypass grafting (CABG), a heart-lung machine assumes temporary control of the heart's pumping function; this technique has gained significant traction and is well-established. This approach is frequently favored due to its effectiveness in managing intricate cases, which has contributed to its prevailing market position. On the contrary, it is expected that the off-pump CABG segment will experience the most rapid growth. There is a discernible inclination towards minimally invasive methods as surgical technology progresses. Off-pump coronary artery bypass grafting (CABG), which obviates the necessity for a heart-lung machine, corresponds to this transition. Potential benefits of the technique include accelerated recovery periods and decreased postoperative complications, which make it an appealing option for both patients and healthcare providers. The increasing demand for minimally invasive procedures places off-pump CABG in a favorable position to experience substantial growth within the global market.
Which Procedure to Be Focused on the Most Regarding Sales?
Single CABG Surgery to be at the Forefront owing to its Intensive Functionality
Because it is the most common primary intervention for patients with coronary artery disease, the single CABG surgery segment is anticipated to hold the largest market share. A single coronary artery graft-backthrough grafting (CABG) procedure is utilized to address isolated occlusions and enhance blood circulation to the heart. The market is anticipated to be dominated by the single CABG surgery segment, owing to its extensive utilization and efficacy. Although the market share of single CABG surgery may be the largest, it is expected that the triple CABG surgery segment will experience the most rapid growth. Triple coronary artery bypass grafting (CABG) is a more comprehensive procedure for patients with advanced coronary artery disease affecting numerous vessels, as it entails the grafting of three coronary arteries. With the ongoing progress in surgical techniques and the rising incidence of complex coronary cases, it is anticipated that the demand for triple CABG surgeries will increase, thereby propelling its substantial expansion in the global market. Triple coronary artery bypass graft surgery is a significant contributor to the evolving landscape of coronary artery bypass graft procedures due to its complexity and efficacy.
Which End Users Are Expected to Benefit the Most from Revenue Generation?
Hospitals to Integrate Technology Rapidly Owing to an Extensive Array of Services
It is anticipated that hospitals will hold the most significant portion of the coronary artery bypass graft (CABG) market. To perform surgical interventions such as CABG, hospitals function as the principal healthcare establishments, offering an extensive array of services and specialized infrastructure tailored to cardiac procedures. The preponderance of CABG procedures are executed within hospital settings, which substantially contributes to the market dominance of this sector. Although hospitals currently possess the largest market share, it is expected that the cardiology clinics segment will experience the most rapid growth. The proliferation of preventive cardiology, technological advancements in diagnostics, and the rising demand for ambulatory cardiac care all contribute to the expansion of cardiology clinics. These clinics are strategically located to meet the increasing need for postoperative care, diagnostic evaluations, and non-invasive procedures; this has contributed to their explosive expansion in the worldwide CABG market.
Why is North America Emerging as a Dominating Region?
Advanced Medical Technologies and Firmly Established Healthcare Infrastructure to Generate Revenue
It is anticipated that North America will hold the largest market share of the worldwide Coronary Artery Bypass Graft (CABG) industry. Numerous elements contribute to this state of dominance. To commence, the advanced medical technologies and firmly established healthcare infrastructure in North America enable extensive accessibility to coronary artery bypass graft procedures. Furthermore, the area exhibits a substantial incidence of cardiovascular ailments, such as coronary artery disease, which drives the need for coronary artery bypass grafts (CABG) procedures. The significant market share in North America is further reinforced by the coexistence of lifestyle-related risk factors and the presence of a substantial geriatric population. Furthermore, the region's leading position in the CABG market can be attributed to its proactive stance towards the adoption of innovative medical interventions and its robust healthcare reimbursement systems. Through its culture of imbibing cutting-edge medical advancements and its highly educated healthcare workforce, North America is anticipated to sustain its dominant position in the worldwide CABG market.
What Opportunities Lie in East Asia for Manufacturers?
Rising Incidence of Cardiovascular Ailments to Promote Growth
It is anticipated that South Asia & Pacific will witness the most rapid expansion of the worldwide CABG market. Numerous elements are at play in this projection. To begin with, the area is currently experiencing a demographic transition characterized by an exponentially expanding populace and a rising incidence of cardiovascular ailments. With the advancement of healthcare infrastructure and increased awareness of advanced cardiac interventions, it is expected that there will be a significant surge in demand for CABG procedures. Furthermore, the proliferation of lifestyle-related risk factors associated with Western influences in several South Asian nations has contributed to the increasing prevalence of coronary artery disease. Although the CABG market in South Asia & Pacific is still in its nascent stages, substantial growth is anticipated in the region due to ongoing economic development, healthcare investments, and a strong emphasis on preventive cardiology. South Asia & Pacific is positioned as the region with the most rapidly expanding coronary artery bypass graft (CABG) market due to the potential for a substantial patient pool and initiatives to improve healthcare accessibility. This creates significant opportunities for market participants and contributes to the global context of coronary artery bypass graft procedures.
Prominent entities in the Coronary Artery Bypass Graft (CABG) industry, including Terumo Corporation, Abbott Laboratories, and Medtronic plc, utilize diverse and complex approaches to maintain and expand their market dominance. As a multinational medical technology corporation, Medtronic plc specializes in all-encompassing cardiovascular care solutions. Constantly innovating in the field of CABG, Medtronic invests heavily in research and development to attain its utmost market share. The company's market leadership is established through its dedication to the development of cutting-edge surgical technologies, such as minimally invasive approaches and robotic-assisted procedures. The extensive international reach of Medtronic facilitates strategic alliances with healthcare establishments, thereby guaranteeing the broad dissemination of its CABG-related products and technologies.
In conclusion, the market leaders in CABG secure and expand their market share through a combination of research and development, innovation, global presence, and strategic partnerships. Through their proactive approach to technological advancements and responsiveness to the changing demands of healthcare systems around the globe, these corporations significantly influence the global coronary artery bypass graft procedure landscape.
Grand Pharmaceutical Group of China invested 15 million euros in August 2022 in Xeltis, a renowned medical device company headquartered in the Netherlands and the clinical-stage phase. Grand Pharmaceutical has developed a cardiovascular restorative device composed of polymers. Coronary artery bypass grafting (CABG) surgery involves the utilization of restoration devices such as heart valves and minor diameter blood vessels.
Market Impact: Grand Pharmaceutical Group's 15 million euro investment in Xeltis signifies a noteworthy market advancement that may have a positive influence on the worldwide Coronary Artery Bypass Graft (CABG) market. The emphasis that Xeltis places on the development of a polymer-based cardiovascular restorative device is consistent with the changing trends in minimally invasive and novel approaches to CABG procedures. This partnership has the potential to yield sophisticated restoration devices, which could transform coronary artery bypass grafting (CABG) surgery by providing innovative polymer-based substitutes for heart valves and blood vessels. Such advancements could potentially enhance patient outcomes and broaden the array of options accessible in the international market.
2023 to 2030
Historical Data Available for
2018 to 2022
US$ Million for Value
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Customization & Pricing
Available upon request
By End User:
The market is anticipated to grow at a CAGR of 2.3%% during the projected period.
The Coronary Artery Bypass Graft market was valued at USD 17,612.1 million in 2023.
The United States held the largest market share in 2023.
The prominent players in the market are Teleflex Incorporated, B. Braun Melsungen AG, Smiths Medical (ICU Medical Inc.), and Becton, Dickinson and Company, among others.
The cardiology clinics segment is expected to grow at the fastest growth during the forecast period.